CAS vs. CEA: Why The Debate Will Never End: Bias And Self Interest Overwhelms Facts And Logic And Often Influences How Good Trials And Even RCTs Are Misinterpreted

When Invasively Treating Asymptomatic Carotid Stenosis (ACS) Patients >75, Should CEA Be Preferred Over TFCAS: Has Anything Changed Or Are The Data From ACT1 And CREST RCTs Showing Comparable Outcomes For The Two Treatments Still Applicable

First Game Changing Results From CREST 2: CEA vs. Best Medical Treatment (BMT) And CAS vs. BMT For ACS: Some 4-Year RESULTS TO DATE Show...

First Game Changing Results From CREST 2: Do They Resolve The Controversy Conclusively Or Are Further Studies Needed

ACST-2 Final Results: This RCT Found That CEA And CAS For ACS Had Comparable Stroke/Death Rates For 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT: Why This Conclusion Is No Longer Applicable

The 2nd European Carotid Surgery Trial (ECST-2): Current Status; 2-Year Results Report And Its Flaws: What It Tells Us And What It Doesn't About BMT vs. Invasive Therapy

Panel Discussion

Optimal Current Management Of Carotid Stenosis After Radiation Therapy For Cancer - Symptomatic And Asymptomatic: What Is The Pathology: How Is It Best Treated And How Results Differ From Standard Carotid Stenosis

Management Options With A Carotid String Sign Or Near Occlusion: Why Are They Controversial: Current Optimal Treatment In Symptomatic And Asymptomatic Patients

Optimal Management Of Asymptomatic Carotid Stenosis With Coexistent Unruptured Intracerebral Aneurysm: Based On A Multicenter Study

Photoacoustic Imaging (With Laser And Ultrasound Derived Information) To Assess Carotid Plaque Vulnerability: How Does It Work And Does It Help

How Can AI Identify And Characterize Vulnerable Carotid Plaque Using A Multi-Modality Approach – How Is This Helpful In Guiding Treatment

Panel Discussion